Sumayya Anwer

Search results

• 2025

  Belantamab mafodotin with bortezomib and dexamethasone for treating relapsed or refractory multiple myeloma after 1 or more treatments: A Single Technology Appraisal

  Uphoff, N., Layne, R. J. L., Gibbs, N. K., Anwer, S., Melton, H. A., Fulbright, H., Parrish, C., Corbett, M. S., Rothery, C., Dias, S. & Duarte, A. I., 24 Jun 2025, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report
• 2024

  Quizartinib for untreated FLT3-ITD-positive acute myeloid leukaemia: A Single Technology Appraisal

  Nevitt, S. J., Llewellyn, A., Deng, J., Coughlan, D., Anwer, S., Marshall, D., Harden, M. & Hodgson, R., 12 Jun 2024, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Selective internal radiation therapy with QuiremSpheres for treating unresectable advanced hepatocellular carcinoma (Partial review of TA688)

  Uphoff, N., Lord, J., Anwer, S., Harden, M., Baker, M., Walton, M. J. & Nevitt, S. J., 3 Jul 2024, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• SQ HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites: A Single Technology Appraisal.

  Corbett, M. S., Phung, H., Anwer, S., Premji, S., Liu, E., Harden, M., Nevitt, S. J., Duarte, A. I., Dias, S. & Saramago Goncalves, P. R., 13 Jun 2024, Centre for Reviews and Dissemination/ Centre for Health Economics. 166 p.

  Research output: Book/Report › Commissioned report

  Open Access
• 2023

  Bimekizumab for treating axial spondyloarthritis: External Assessment Group Report for the National Institute for Health and Care Excellence

  Walker, R. A. E., Anwer, S., Gao, M., Umemneku-Chikere, C., Harden, M., Duarte, A. I. & Dias, S., Oct 2023, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

  Open Access

• Dupilumab for treating prurigo nodularis: External Assessment Group Report for the National Institute for Health and Care Excellence

  Corbett, M. S., Zhou, A., Anwer, S., Wade, R., Chen, T., Fulbright, H. A., Bojke, L., Eastwood, A. J. & Rothery, C., Aug 2023, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Pembrolizumab with chemotherapy for treating recurrent, persistent or metastatic cervical cancer [ID3798]Pembrolizumab with chemotherapy for treating recurrent, persistent or metastatic cervical cancer

  Rodgers, M., Walton, M. J., Anwer, S., Corbett, M. S., Njoroge, M. W., Fulbright, H. A., Naik, R., Powell, M., Eastwood, A. J. & Hodgson, R., 29 Mar 2023, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Tofacitinib for treating active ankylosing spondylitis: A Fast Track Appraisal. Evidence Review Group Report for the National Institute for Health and Care Excellence

  Corbett, M. S., Walker, R. A. E., Anwer, S., Shepherd, L., Walton, M. J., Fulbright, H. A., Phung, H., Soares, M. O., Rothery, C., Duarte, A. I. & Dias, S., 18 Oct 2023, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• 2022

  Upadacitinib for treating active ankylosing spondylitis: A Fast Track Appraisal. Evidence Review Group Report for the National Institute for Health and Care Excellence

  Walker, R. A. E., Corbett, M. S., Beresford, L., Anwer, S., Duarte, A. I., Fulbright, H. A., Phung, H., Soares, M. O., Rothery, C., Walton, M. J. & Dias, S., 2022, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report
• 2021

  Baricitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis

  Hodgson, R., Sharif, S., Beresford, L., Anwer, S., Walton, M. J., Wittmann, M., Harden, M., Khouja, C. L. & Dias, S., 3 Mar 2021, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Betibeglogene autotemcel for treating transfusion-dependent beta-thalassaemia: A Single Technology Appraisal

  Claxton, L., Corbett, M. S., Walton, M. J., Murphy, P. J., Anwer, S., Harden, M. & Dias, S., 11 Feb 2021, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Cenobamate for adjunctive treatment of focal epilepsy: Evidence Review Group Report for the National Institute for Health and Care Excellence

  Jankovic, D., Llewellyn, A., Anwer, S., Harden, M., Faria, R., Rothery, C., Eastwood, A. J. & Saramago Goncalves, P. R., 2021, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Daratumumab in combination for newly diagnosed systemic amyloid light-chain amyloidosis: Evidence Review Group Report for the National Institute for Health and Care Excellence

  Faria, R., Rodgers, M., Saramago Goncalves, P. R., Anwer, S., Fulbright, H. A., Lachmann, H., Wechalekar, A., Dias, S. & Rothery, C., 2021, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Meta-Analysis: Guideline Methodology Document 1

  Daly, C., Dias, S., Welton, N. J., Anwer, S. & Ades, A. E., Jan 2021, NICE Guidelines Technical Support Unit. 39 p.

  Research output: Book/Report › Commissioned report

  Open Access

• Meta-Analysis of Continuous Outcomes: Guideline Methodology Document 2

  Daly, C., Welton, N. J., Dias, S., Anwer, S. & Ades, A. E., Jan 2021, NICE Guidelines Technical Support Unit. 49 p.

  Research output: Book/Report › Commissioned report

  Open Access

• Meta-Analysis of Event Outcomes: Guideline Methodology Document 3

  Daly, C., Anwer, S., Welton, N. J., Dias, S. & Ades, A. E., Jan 2021, NICE Guidelines Technical Support Unit. 38 p.

  Research output: Book/Report › Commissioned report

  Open Access